Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis

Long-Term Safety and Efficacy of Topical Cyclosporine in 156 Children with Vernal Keratoconjunctivitis

(2017) N. Pucci et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Vernal keratoconjunctivitis: A severe allergic eye disease with remodeling changes

(2014) Pakit Vichyanond et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Topical Cyclosporine in the Treatment of Allergic Conjunctivitis

(2013) Kelvin Ho-Nam Wan et al.   OPHTHALMOLOGY

Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial

(2011) Stefan De Smedt et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children

(2009) Riccardina Tesse et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Vernal keratoconjunctivitis: a major review

(2008) Sunil Kumar   ACTA OPHTHALMOLOGICA

Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children

(2008) Ugur Keklikci et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY